Skip to main content
Tara Mitchell, MD, Oncology, Philadelphia, PA

TaraCMitchellMD

Oncology • Philadelphia, PA

Hematologic Oncology, Melanoma

Associate Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Mitchell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mitchell's full profile

Already have an account?

  • Office

    3400 Civic Center Blvd
    South Pavilion, 10th Floor
    Philadelphia, PA 19104
    Phone+1 215-615-5858
    Fax+1 215-662-4646

Summary

  • Dr. Tara Mitchell is an oncologist in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania. She received her medical degree from NYU Grossman School of Medicine and has been in practice 13 years. She specializes in hematologic oncology and melanoma and is experienced in mohs micrographic surgery, melanoma and cutaneous malignancies, combined modality therapy, drug interactions, and immunologic adjuvants.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 2007 - 2010
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Internal Medicine, 2004 - 2007
  • New York University School of Medicine
    New York University School of MedicineClass of 2004
  • Columbia University
    Columbia UniversityBA, Anthropology

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2011 - 2024
  • PA State Medical License
    PA State Medical License 2020 - 2024
  • IL State Medical License
    IL State Medical License 2007 - 2011
  • American Board of Clinical PharmacologyClinical Pharmacology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Exosomal PD-L1 Contributes to Immunosuppression and Is Associated with Anti-PD-1 Response  
    Xiaowei Xu, Haidong Dong, Tara C Mitchell, Lynn M Schuchter, Alexander C Huang, Suzanne McGettigan, Wei Xu, Giorgos C Karakousis, Xiaoming Liu, Gordon Mills, Nature
  • Timing of Onset of Adverse Cutaneous Reactions Associated with Programmed Cell Death Protein 1 Inhibitor Therapy  
    Tara C Mitchell, Michael E Ming, Leo L Wang, Suzanne McGettigan, Emily Y Chu, Lynn Schuchter, JAMA
  • Pathological Assessment of Resection Specimens After Neoadjuvant Therapy for Metastatic Melanoma  
    M T Tetzlaff, J E Gershenwald, X Xu, V G Prieto, T Mitchell, M A Davies, J M Taube, Annals of Oncology

Press Mentions

  • Penn Medicine’s Tara Miller Melanoma Center Is a Trailblazer for Skin Cancer Treatment
    Penn Medicine’s Tara Miller Melanoma Center Is a Trailblazer for Skin Cancer TreatmentJune 2nd, 2022
  • Penn Medicine and Wistar Secure $11.7 Million SPORE Grant for Three Melanoma Research Projects
    Penn Medicine and Wistar Secure $11.7 Million SPORE Grant for Three Melanoma Research ProjectsSeptember 22nd, 2021
  • A Single Dose of a PD-1 Inhibitor Before Surgery Predicts Outcomes in Melanoma Patients
    A Single Dose of a PD-1 Inhibitor Before Surgery Predicts Outcomes in Melanoma PatientsFebruary 25th, 2019
  • Join now to see all

Grant Support

  • Career Development AwardMelanoma SPORE, Penn2014
  • Young Investigator AwardMelanoma Research Foundation2012–2014

Professional Memberships

Dr. Tara Mitchell, Dr. Tara Mitchell, MD, Dr. T Mitchell, Dr. Tara C Mitchell